Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8862 |
High Similarity |
NPD5844 |
Phase 1 |
0.8788 |
High Similarity |
NPD6232 |
Discontinued |
0.8631 |
High Similarity |
NPD7473 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8476 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8438 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8438 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8415 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8364 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8313 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8225 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD919 |
Approved |
0.8155 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8144 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.807 |
Intermediate Similarity |
NPD1247 |
Approved |
0.805 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8023 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7966 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7956 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7943 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7927 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7898 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7882 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7836 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7816 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7784 |
Intermediate Similarity |
NPD920 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD37 |
Approved |
0.775 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7746 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7744 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7733 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7733 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7709 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7709 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7683 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7669 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD1240 |
Approved |
0.761 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7576 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7576 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7487 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7439 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7418 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7384 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7326 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7321 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD943 |
Approved |
0.7296 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7229 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7195 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7186 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD411 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7003 |
Approved |
0.711 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7107 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7099 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7081 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7073 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7065 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7065 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7044 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7038 |
Approved |
0.6984 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD4288 |
Approved |
0.6974 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6965 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD5691 |
Approved |
0.6959 |
Remote Similarity |
NPD6535 |
Approved |
0.6959 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6534 |
Approved |
0.6951 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6946
|
Remote Similarity |
NPD5124 |
Phase 1 |